Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides
- PMID: 9008608
- DOI: 10.1002/art.1780400117
Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides
Abstract
Objective: To investigate potential mechanisms by which CD40L-mediated signals may be involved in the pathogenesis of lupus glomerulonephritis (GN).
Methods: Renal in situ CD40L and CD40 expression was examined in patient biopsy specimens. Immunohistochemical studies were performed on frozen sections utilizing anti-CD40L monoclonal antibody (MAb), anti-CD40 MAb, or control MAb. As controls, we analyzed normal kidney specimens and specimens obtained from patients with IgA nephropathy, focal segmental glomerulosclerosis, minimal change disease, idiopathic membranous GN, and antineutrophil cytoplasmic antibody-positive pauci-immune GN. Staining distribution was noted and staining intensity scored on a semiquantitative scale of 0 (no staining) to 3+ (intense staining).
Results: In normal kidney, CD40 was expressed on parietal epithelial cells, mesangial cells, endothelial cells, and distal tubules but not proximal tubules. Glomerular and tubular CD40 expression was markedly up-regulated in class III and class IV lupus GN, where there was intense staining of crescents, proximal and distal tubules, and interstitial mononuclear cells. In contrast, CD40 expression in class V lupus GN was similar to that in normal kidney. Interstitial mononuclear cells expressing CD40L were present in class IV lupus GN. However, these findings were not unique to lupus GN: up-regulation of CD40 and CD40L expression was similarly observed in other inflammatory renal diseases.
Conclusion: This study shows that CD40 is expressed on a variety of renal parenchymal and non-parenchymal cells in normal kidney. Renal CD40 expression is up-regulated in class III and class IV lupus nephritis, as well as in other inflammatory renal diseases, and is associated with the presence of CD40L+ mononuclear cells.
Similar articles
-
Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.Autoimmun Rev. 2020 Nov;19(11):102668. doi: 10.1016/j.autrev.2020.102668. Epub 2020 Sep 14. Autoimmun Rev. 2020. PMID: 32942031 Review.
-
In situ upregulation of IL-10 reflects the activity of human glomerulonephritides.Am J Kidney Dis. 1998 Jul;32(1):80-92. doi: 10.1053/ajkd.1998.v32.pm9669428. Am J Kidney Dis. 1998. PMID: 9669428
-
CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.Kidney Int. 1999 Apr;55(4):1543-52. doi: 10.1046/j.1523-1755.1999.00379.x. Kidney Int. 1999. PMID: 10201021
-
Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.J Clin Invest. 1982 Apr;69(4):900-12. doi: 10.1172/jci110529. J Clin Invest. 1982. PMID: 7042757 Free PMC article.
-
[Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].G Ital Nefrol. 2003 Sep-Oct;20 Suppl 24:S3-47. G Ital Nefrol. 2003. PMID: 14666502 Review. Italian.
Cited by
-
New therapies in development for autoimmune diseases: their rationale for combination treatment.Springer Semin Immunopathol. 2001;23(1-2):43-61. doi: 10.1007/s002810100071. Springer Semin Immunopathol. 2001. PMID: 11455860 Review. No abstract available.
-
Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy.J Clin Med. 2023 Mar 3;12(5):2023. doi: 10.3390/jcm12052023. J Clin Med. 2023. PMID: 36902810 Free PMC article.
-
The dinucleotide repeat polymorphism in the 3'UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus.Ann Rheum Dis. 2004 Mar;63(3):310-7. doi: 10.1136/ard.2003.006148. Ann Rheum Dis. 2004. PMID: 14962968 Free PMC article.
-
Outcome of Patients With Lupus Nephritis Treated With an Anti-CD40 Monoclonal Antibody According to Kidney Biopsy Features.Arthritis Rheumatol. 2025 Jun;77(6):696-704. doi: 10.1002/art.43076. Epub 2025 Jan 28. Arthritis Rheumatol. 2025. PMID: 39648337 Free PMC article. Clinical Trial.
-
Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus.J Immunol. 2019 Jul 1;203(1):58-75. doi: 10.4049/jimmunol.1900043. Epub 2019 May 20. J Immunol. 2019. PMID: 31109957 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous